0D534Z3
Destruction Esophagus, Lower to Laser Interstitial Thermal Therapy with No Device, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | D Gastrointestinal System |
| Operation | 5 Destruction |
| Body Part | 3 Esophagus, Lower |
| Approach | 4 Percutaneous Endoscopic |
| Device | Z No Device |
| Qualifier | 3 Laser Interstitial Thermal Therapy |
Operation Definition
Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent
Procedure Overview
This family describes procedures that destroy diseased gastrointestinal tissue in place, using heat, cold, laser light, chemical agents, or other energy sources, rather than cutting the tissue out and removing it from the body. Common targets include bleeding ulcers treated with electrocautery, small polyps ablated during colonoscopy, internal hemorrhoids treated with infrared coagulation or sclerosing injection, and Barrett's esophagus tissue eradicated with radiofrequency ablation.
Patients undergo these procedures when a lesion is too small, too diffuse, or too risky to remove surgically, or when destroying abnormal cells in place - such as precancerous esophageal lining - offers a lower-risk alternative to resection. The eradicated tissue remains in the body and is broken down and absorbed rather than being sent to pathology.
Anatomy & Axis Detail
Esophagus, Lower
The lower esophagus extends from the mid-thoracic region to the esophagogastric junction and is the segment most frequently affected by chronic acid reflux, making it the classic site for Barrett's esophagus and associated dysplasia. Destruction procedures here, such as radiofrequency ablation or cryotherapy, eliminate abnormal or precancerous mucosa in place, reducing progression risk to adenocarcinoma without removing the esophageal wall itself. Because reflux disease concentrates its damage in this distal segment due to prolonged acid exposure near the junction, destructive endoscopic therapy is a common alternative to surgical resection for early-stage disease confined to the mucosa. Documentation should confirm the treated tissue was ablated rather than excised, and should distinguish the lower esophagus from the adjacent esophagogastric junction when lesions span that boundary.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Qualifier: Laser Interstitial Thermal Therapy
Laser Interstitial Thermal Therapy is a qualifier used with the root operation Destruction, most often on brain tissue, denoting that tissue is ablated using a stereotactically placed laser probe delivering thermal energy under real-time MRI thermography guidance. It is distinguished from Stereoelectroencephalographic Radiofrequency Ablation, which uses electrode-delivered RF current instead of light energy, and from unqualified Destruction, which does not specify laser technique.
Coding & Documentation
Coders select this family when documentation describes the lesion or tissue being burned, frozen, lased, or chemically destroyed, with no mention of tissue being excised and removed as a specimen. Operative notes should clearly identify the destructive modality used and the anatomic site treated. The most frequent coding error is treating a polypectomy where the polyp is snared and physically removed as Destruction when it should be Excision - the deciding factor is whether tissue leaves the body. A second common mistake is applying a single Destruction code to multiple distinct lesions treated in one session when separate body part values are actually warranted.